Impact of COVID-19. The Hawai’i state Department of Health (HDOH) has reported that during the current pandemic, the virus that causes COVID-19 (SARS-CoV-2) has caused >1600 deaths in the state.
How to Best Protect Yourself and Your Community? Ensuring your COVID-19 vaccinations are up-to-date provides protection for you, your family, friends, roommates, and co-workers. Currently authorized vaccines are safe and effective; these also lower the risk of severe COVID-19 outcomes. Also, wear a mask (at schools, health facilities, long-term care facilities or crowded venues), practice hand hygiene, cough etiquette, and don’t go to work if you have COVID-19 symptoms.
Which Variants are Circulating? The State Laboratories Division (SLD) of HDOH routinely tests a fraction of COVID-19 specimens. The SLD Report in October confirms that BA.5 and BA.4.6 are most common variants causing illness in the state.
Vaccines Effective against BA.5 & BA 4.6 Variants? The newly authorized bivalent Boosters are safe, and effective against these Omicron variants. A bivalent booster dose is strongly recommended for anyone >50 years of age, or living in a skilled nursing facility or other congregate setting, or for persons with co-morbidities, including: chronic heart or lung disease, diabetes, obesity, cancer, or an immunodeficiency.
Pre-Exposure Prophylaxis (PreP) Available for Immunocompromised Patients:
- FDA has authorized COIVD-19 Pre-Exposure Prophylaxis with EVUSHELD in moderately or severely immunocompromised patients or individuals who experienced a severe adverse reaction (e.g., anaphylaxis) after COVID-19 vaccination (see FDA fact sheet for detailed in vitro susceptibility data on Omicron variants).
Additional Resources for Clinicians, Pharmacists:
- Outpatient (1-page) Oral COVID-19 Treatment Summary for Medical Providers
- Side-by-Side Overview of All Antivirals Authorized for Mild-Moderate COVID-19
- Recommendations for Treating COVID-19 in Nonhospitalized Adults (NIH)
- Clinical Guidelines on Therapeutics for Outpatient Treatment of COVID-19
- COVID-19 Therapeutics Locator (HHS/ASPR)
- COVID-19 Test to Treat Locator (HHS/ASPR)
- COVID-19 Treatment Guidelines for Non-Hospitalized Adults (NIH)
- Prioritization of anti-SARS-CoV-2 Therapies (NIH)
- Treatment of Outpatients with Mild to Moderate COVID-19 (CDC Health Advisory)
Resources for Patients and Caregivers:
*Note: Patients should discuss treatment with their physician, healthcare provider or pharmacist; please call before visiting if you are experiencing any COVID-19 symptoms.
Last updated 10/17/2022